Therapeutic Asset Ratings

217 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Tepotinib Non-small Cell Lung Cancer	Memorial Sloan Kettering Cancer Center	P3	B (63)
Calcium folinate pentahydrate Non-small Cell Lung Cancer	Tango Therapeutics, Inc.	P4	B (62)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Non-small Cell Lung Cancer	University of Chicago	P3	B (62)
Pyrotinib Non-small Cell Lung Cancer	RemeGen Co., Ltd.	P3	B (62)
Toripalimab Non-small Cell Lung Cancer	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	P3	B (62)
PEGFILGRASTIM Non-small Cell Lung Cancer	University of California, Irvine	P4	B (61)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER Non-small Cell Lung Cancer	University of Chicago	P3	B (61)
Osimertinib Non-small Cell Lung Cancer	Shanghai Allink Biotherapeutics Co., Ltd.	P3	B (61)
Tiragolumab Non-small Cell Lung Cancer	Hoffmann-La Roche	P3	B (61)
Irinotecan Non-small Cell Lung Cancer	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P2	B (61)
Brigatinib Non-small Cell Lung Cancer	M.D. Anderson Cancer Center	P3	B (60)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER Non-small Cell Lung Cancer	City of Hope Medical Center	P3	B (60)
FLUOROURACILUM Non-small Cell Lung Cancer	Fudan University	P3	B (59)
Dc-Cik Non-small Cell Lung Cancer	Tianjin Medical University Cancer Institute and Hospital	P2/3	B (59)
Vorinostat Non-small Cell Lung Cancer	H. Lee Moffitt Cancer Center and Research Institute	P2/3	B (59)
gsk1120212 Non-small Cell Lung Cancer	Novartis Pharmaceuticals	P4	B (58)
MIDAZOLAM Non-small Cell Lung Cancer	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P4	B (58)
Capecitabine Non-small Cell Lung Cancer	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P3	B (58)
Envafolimab Non-small Cell Lung Cancer	City of Hope Medical Center	P3	B (58)
JAB 3312 Non-small Cell Lung Cancer	Allist Pharmaceuticals, Inc.	P3	B (58)
Monalizumab Non-small Cell Lung Cancer	Montefiore Medical Center	P3	B (58)
S-1 Non-small Cell Lung Cancer	Genentech, Inc.	P3	B (58)
sy-3505 Non-small Cell Lung Cancer	Shouyao Holdings (Beijing) Co. LTD	P3	B (58)
Volrustomig Non-small Cell Lung Cancer	AstraZeneca	P3	B (58)
wx-0593 Non-small Cell Lung Cancer	Pingping Song	P3	B (58)

Showing 26 to 50 of 217 assets

PreviousPage 2 of 9Next